Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year, prospective cohort study.

Hepatocellular carcinoma (HCC) is the most frequent cause of death in patients with hepatitis
C virus (HCV)–induced cirrhosis. Despite a number of studies in different populations
worldwide suggesting an association between HCV genotype 1 and the risk of HCC, no
consensus has emerged yet on this matter, which is still controversial. In an attempt to clarify
this issue, a prospective study of 163 consecutive HCV-positive patients with cirrhosis, who
were enrolled between January 1989 and December 1990, was carried out. HCC occurrence
was detected by ultrasound surveillance every 6 months. Independent predictors of HCC
were assessed with a Cox regression analysis. After a median follow-up of 10.7 years, 44
[4.26/100/year, confidence interval (CI) 3.11-5.68/100/year] of 104 patients infected
with genotype 1b developed HCC versus 10 (1.69/100/year, CI0.82-3.09/100/year) of 52
patients infected with genotype 2a/c (P 0.0001). Multivariate analysis showed that HCV
genotype 1b was independently associated with HCC development [hazard ratio (HR)
3.02, 95% CI 1.40-6.53]. Other predictors of HCC were esophageal varices (HR 2.15,
95% CI1.03-4.47), male gender (HR2.12, 95% CI1.10-4.11), and age over 60 years
(HR 5.96, 95% CI 1.23-28.8). Conclusion: HCV genotype 1b is associated with a
statistically significant higher risk of developing HCC. Patients with cirrhosis that are
infected with this genotype require more intensive surveillance for the early detection and
aggressive management of neoplasia. (HEPATOLOGY 2007;46:1350-1356.)